Search results for: Mental Health
Filter search results
New OHE Consulting Report Explores the Many Faces of Innovation
19 June 2012
…important innovation that has occurred since the earlier report, adds new case studies, and updates the discussion of competition in pharmaceutical R&D. In the context of increasing pressure on health…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
…countries with comprehensive insurance, the authors discuss the appropriate use of an incremental cost-effectiveness ratio (ICER) that reflects citizens’ willingness to pay for health gain. They note that current regulatory structures…
NICE Decisions: Exploring the Influence of Cost-Effectiveness and Other Factors
30 April 2013
…Rice of the University of York, and David Parkin, senior visiting researcher at OHE. Factors Influencing Decisions by NICE from Office of Health Economics Established in 1999, the National Institute…
OHE Welcomes Professors Rawlins and Smith to its Policy Board
6 May 2013
…the University of Newcastle upon Tyne. Professor Peter C. Smith is co-director of the Centre for Health Policy in the Institute of Global Health Innovation at Imperial College London and…
Assessing Use of the EQ-VAS in the NHS PROMs Programme
12 November 2013
…asks patients to classify their health based on self-assessed levels of problems (“no”, “some”, “extreme”). The second is the EQ-VAS, which asks patients to indicate their overall health on a…
NICE Decisions: Cost-effectiveness is the Most Significant Predictor
21 November 2013
Using data for 1999-2011, this thorough analysis explores what has most influenced NICE’s decisions and whether this has changed. Established in 1999, the National Institute for Health and Care Excellence…
Innovation in Oncology: Real Option Value and Path Dependence
29 April 2014
…through the pricing of new medicines given the limitations of the information available at launch. As the author points out, oncology drugs in particular often follow the path of incremental…
Spotlight on OHE: Innovation, Regulation and Antibiotics
30 September 2014
…about value on the incremental cost to the tax-funded health and social care services of the additional quality-adjusted life years (QALYs) a new medicine offers to patients. During the last…
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
…conceptual idea of “value” into two components, clinical care value and health system value. Judgements as to the clinical care value of drugs and devices are based on five elements:…